O-Benzyl-hydroxylamine hydrochloride, 97.00%, 10kg

Bis(4-tert-butylphenyl)iodonium Hexafluoroantimonate>98.0%(HPLC)25g

N,N-Dimethylindoline-5-sulfonamide, 95.0%, 5g

GC capillary column ROTI®Cap-5, 50 m, 0.20 mm, 0.50 µm, 1 Piece(s)

(R)-N-(pyrrolidin-3-yl)cyclopropanecarboxamide hydrochloride, 98%, 250mg

Methyl 4-(2,2-diethoxyethoxy)benzoate, 95+%, 5g

9-Fluorenone-4-carboxylic Acid>98.0%(HPLC)(T)1g

(S)-4-Phenyl-2-(2-(pyridin-2-yl)propan-2-yl)-4,5-dihydrooxazole, 97%, 100mg

(S)-(-)-1,1,2-Triphenylethane-1,2-diol, 98.0%, 5g

(S)-2-Amino-3-(2-cyanophenyl)propanoic acid, 95.0%, 250mg

(R)-methyl 2-((R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate, 95%, 1g

Omaveloxolone, 99.40%, 25mg

Methyl 2,5-dihydrothiophene-3-carboxylate 1,1-dioxide, 95.0%, 5g